Title:
ULK INHIBITORS
Document Type and Number:
WIPO Patent Application WO/2024/099225
Kind Code:
A1
Abstract:
Disclosed are a class of ULK inhibitors. Specifically, the present invention relates to a compound as represented by general formula (1) and a preparation method therefor, and the use of the compound of general formula (1) and an isomer, a crystal form, a pharmaceutically acceptable salt, a hydrate or a solvate thereof as an ULK inhibitor in the preparation of an anti-tumor drug.
Inventors:
XIE YULI (CN)
WU YINGMING (CN)
QIAN LIHUI (CN)
WU YINGMING (CN)
QIAN LIHUI (CN)
Application Number:
PCT/CN2023/129511
Publication Date:
May 16, 2024
Filing Date:
November 03, 2023
Export Citation:
Assignee:
WIGEN BIOMEDICINE TECH SHANGHAI CO LTD (CN)
International Classes:
C07D403/12; A61K31/444; A61K31/506; A61P35/00; C07D403/14
Foreign References:
| US20100056524A1 | 2010-03-04 | |||
| US20030171359A1 | 2003-09-11 | |||
| CN114127057A | 2022-03-01 |
Attorney, Agent or Firm:
SHANGHAI BESHINING LAW OFFICE (CN)
Download PDF: